BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31177174)

  • 1. The Role of DNA Repair Glycosylase OGG1 in Intrahepatic Cholangiocarcinoma.
    Sakata K; Yoshizumi T; Izumi T; Shimokawa M; Itoh S; Ikegami T; Harada N; Toshima T; Mano Y; Mori M
    Anticancer Res; 2019 Jun; 39(6):3241-3248. PubMed ID: 31177174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative DNA damage in human esophageal cancer: clinicopathological analysis of 8-hydroxydeoxyguanosine and its repair enzyme.
    Kubo N; Morita M; Nakashima Y; Kitao H; Egashira A; Saeki H; Oki E; Kakeji Y; Oda Y; Maehara Y
    Dis Esophagus; 2014 Apr; 27(3):285-93. PubMed ID: 23902537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.
    Tanaka M; Shibahara J; Ishikawa S; Ushiku T; Morikawa T; Shinozaki-Ushiku A; Hayashi A; Misumi K; Tanaka A; Katoh H; Sakuma K; Kokudo T; Inagaki Y; Arita J; Sakamoto Y; Hasegawa K; Fukayama M
    Virchows Arch; 2019 Jan; 474(1):39-46. PubMed ID: 30349952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of 8-hydroxy-deoxyguanosine and its repair enzyme 8-hydroxy-deoxyguanosine DNA glycosylase in hepatocellular carcinoma.
    Yugawa K; Itoh S; Yoshizumi T; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
    Pathol Int; 2020 Aug; 70(8):533-541. PubMed ID: 32419286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced MUTYH, MTH1, and OGG1 expression and TP53 mutation in diffuse-type adenocarcinoma of gastric cardia.
    Kohno Y; Yamamoto H; Hirahashi M; Kumagae Y; Nakamura M; Oki E; Oda Y
    Hum Pathol; 2016 Jun; 52():145-52. PubMed ID: 26980051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
    Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
    Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial expression of the DNA repair enzyme OGG1 improves the prognosis of pancreatic ductal adenocarcinoma.
    Inokuchi S; Itoh S; Yoshizumi T; Yugawa K; Yoshiya S; Toshima T; Takeishi K; Iguchi T; Sanefuji K; Harada N; Sugimachi K; Ikegami T; Kohashi K; Taguchi K; Yonemasu H; Fukuzawa K; Oda Y; Mori M
    Pancreatology; 2020 Sep; 20(6):1175-1182. PubMed ID: 32741713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma.
    Schmitz KJ; Lang H; Wohlschlaeger J; Reis H; Sotiropoulos GC; Schmid KW; Baba HA
    Virchows Arch; 2007 Feb; 450(2):135-41. PubMed ID: 17165088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of G
    Cao XY; Ji HJ; Zhou YJ; Lu XF; Shen JY; Wu ZR; Bu H; Shi YJ
    Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):638-644. PubMed ID: 29291784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative DNA damage and reduced expression of DNA repair genes: Role in primary open angle glaucoma (POAG).
    Mohanty K; Dada R; Dada T
    Ophthalmic Genet; 2017; 38(5):446-450. PubMed ID: 28129013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair gene OGG1 polymorphism and its relation with oxidative DNA damage in patients with Alzheimer's disease.
    Dinçer Y; Akkaya Ç; Mutlu T; Yavuzer S; Erkol G; Bozluolcay M; Guven M
    Neurosci Lett; 2019 Sep; 709():134362. PubMed ID: 31299287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism.
    Farinati F; Cardin R; Bortolami M; Nitti D; Basso D; de Bernard M; Cassaro M; Sergio A; Rugge M
    Int J Cancer; 2008 Jul; 123(1):51-5. PubMed ID: 18366059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma.
    Talabnin C; Janthavon P; Thongsom S; Suginta W; Talabnin K; Wongkham S
    Hum Pathol; 2016 Jun; 52():47-54. PubMed ID: 26980022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study.
    Bi C; Liu M; Rong W; Wu F; Zhang Y; Lin S; Liu Y; Wu J; Wang L
    BMC Cancer; 2019 Mar; 19(1):213. PubMed ID: 30849962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss.
    Misumi K; Hayashi A; Shibahara J; Arita J; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M
    Histopathology; 2017 Apr; 70(5):766-774. PubMed ID: 27864835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative cell injury as a predictor of endometriosis progression.
    Carvalho LF; Abrão MS; Biscotti C; Sharma R; Nutter B; Falcone T
    Reprod Sci; 2013 Jun; 20(6):688-98. PubMed ID: 23287096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma.
    Sarcognato S; Gringeri E; Fassan M; Di Giunta M; Maffeis V; Guzzardo V; Cillo U; Guido M
    Virchows Arch; 2019 Jan; 474(1):29-37. PubMed ID: 30377796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve Growth Factor Expression Is Not Associated with Perineural Invasion in Extrahepatic Cholangiocarcinoma.
    Urabe K; Murakami Y; Kondo N; Uemura K; Hashimoto Y; Nakagawa N; Sasaki H; Hiyama E; Takahashi S; Sueda T
    Dig Dis Sci; 2016 Mar; 61(3):774-84. PubMed ID: 26547754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OGG1 DNA Repair Gene Polymorphism As a Biomarker of Oxidative and Genotoxic DNA Damage.
    Miglani K; Kumar S; Yadav A; Aggarwal N; Gupta R
    Iran Biomed J; 2021 Jan; 25(1):47-53. PubMed ID: 33129239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.